• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Mini Sarcopenia 风险评估(MSRA)问卷评分作为骨骼肌质量损失的预测指标。

The Mini Sarcopenia Risk Assessment (MSRA) Questionnaire score as a predictor of skeletal muscle mass loss.

机构信息

Department of Medicine, Geriatrics Division, University of Verona, Ospedale Maggiore, Piazzale Stefani 1, 37126, Verona, Italy.

Department of Medicine, University of Verona, Verona, Italy.

出版信息

Aging Clin Exp Res. 2021 Sep;33(9):2593-2597. doi: 10.1007/s40520-020-01763-1. Epub 2021 Jan 2.

DOI:10.1007/s40520-020-01763-1
PMID:33389711
Abstract

BACKGROUND

Previous studies showed a strong relationship between reduction of appendicular muscle mass and worsening disability; hence, accuracy in assessing muscle mass is considered a key feature for a sarcopenia screening tool.

AIM

The aim of the study was to evaluate if the 7 items of Mini Sarcopenia Risk Assessment (MSRA) questionnaire predict muscle mass loss in a population of community-dwelling elderly subjects over a 5.5-y follow-up.

METHODS

The study included 159 subjects, 92 women and 67 men aged 71.5 ± 2.2 years and with mean body mass index of 26.7 ± 4.0 kg/m. Appendicular skeletal muscle mass (ASMM) as measured with Dual-Energy X-ray absorptiometry (DXA), was obtained at baseline and after 2 and 5.5 years of follow-up where the skeletal muscle index (SMI) was calculated.

RESULTS

A significant reduction of ASMM and SMI was observed at two and 5.5 years of follow-up, in both, men and women. Repeated-measures analysis of variance (ANOVA) found a significant time effect on ASMM for both subjects with MSRA > 30 and ≤ 30 (P < 0.01 and P < 0.001). The group × time interaction was significant (P < 0.001), after even considering separately subjects with normal muscle mass and low muscle mass at baseline (P < 0.05 and P = 0.005). Similar results were obtained for SMI. Considering only the subjects with normal SMI at baseline, subjects with MSRA questionnaire ≤ 30 showed 5.7 (95% CI 1.73-19.03) higher risk of exceeding the low muscle mass threshold.

CONCLUSION

In a population of community-dwelling elderly men and women, MSRA score of 30 is predictive of a steeper decline in ASMM and SMI and of a higher risk of exceeding the low muscle mass EWGSOP threshold.

摘要

背景

先前的研究表明,四肢肌肉质量的减少与残疾程度的恶化之间存在很强的关系;因此,准确评估肌肉质量被认为是肌少症筛查工具的关键特征。

目的

本研究旨在评估迷你肌少症风险评估(MSRA)问卷的 7 项条目是否可预测社区居住的老年人群在 5.5 年随访中肌肉质量的丧失。

方法

该研究纳入了 159 名受试者,其中 92 名女性,67 名男性,年龄为 71.5±2.2 岁,平均体重指数为 26.7±4.0kg/m2。使用双能 X 射线吸收法(DXA)测量四肢骨骼肌质量(ASMM),在基线和随访 2 年和 5.5 年后获得骨骼肌指数(SMI)。

结果

在男性和女性中,均观察到 ASMM 和 SMI 在随访 2 年和 5.5 年时显著减少。重复测量方差分析(ANOVA)发现,对于 MSRA>30 和 MSRA≤30 的受试者,ASMM 存在显著的时间效应(P<0.01 和 P<0.001)。组×时间的交互作用有显著差异(P<0.001),即使考虑到基线时肌肉质量正常和低的受试者也是如此(P<0.05 和 P=0.005)。SMI 也得到了类似的结果。仅考虑基线时 SMI 正常的受试者,MSRA 问卷≤30 的受试者,其超过低肌肉质量阈值的风险增加了 5.7(95%CI 1.73-19.03)。

结论

在社区居住的老年男性和女性人群中,MSRA 评分 30 可预测 ASMM 和 SMI 下降更快,超过 EWGSOP 低肌肉质量阈值的风险更高。

相似文献

1
The Mini Sarcopenia Risk Assessment (MSRA) Questionnaire score as a predictor of skeletal muscle mass loss.Mini Sarcopenia 风险评估(MSRA)问卷评分作为骨骼肌质量损失的预测指标。
Aging Clin Exp Res. 2021 Sep;33(9):2593-2597. doi: 10.1007/s40520-020-01763-1. Epub 2021 Jan 2.
2
Assessing the Risk of Sarcopenia in the Elderly: The Mini Sarcopenia Risk Assessment (MSRA) Questionnaire.评估老年人肌肉减少症风险:简易肌肉减少症风险评估(MSRA)问卷
J Nutr Health Aging. 2017;21(6):743-749. doi: 10.1007/s12603-017-0921-4.
3
Sarcopenia Risk Evaluation in a Sample of Hospitalized Elderly Men and Women: Combined Use of the Mini Sarcopenia Risk Assessment (MSRA) and the SARC-F.住院老年男性和女性的肌肉减少症风险评估:Mini Sarcopenia 风险评估(MSRA)和 SARC-F 的联合应用。
Nutrients. 2021 Feb 16;13(2):635. doi: 10.3390/nu13020635.
4
Physical disability and muscular strength in relation to obesity and different body composition indexes in a sample of healthy elderly women.在一组健康老年女性样本中,身体残疾和肌肉力量与肥胖及不同身体成分指标的关系。
Int J Obes Relat Metab Disord. 2004 Feb;28(2):234-41. doi: 10.1038/sj.ijo.0802552.
5
Sarcopenia and Appendicular Muscle Mass as Predictors of Impaired Fasting Glucose/Type 2 Diabetes in Elderly Women.骨骼肌减少症和四肢骨骼肌质量与老年女性空腹血糖受损/2 型糖尿病的相关性研究。
Nutrients. 2021 Jun 2;13(6):1909. doi: 10.3390/nu13061909.
6
Sarcopenic obesity assessed using dual energy X-ray absorptiometry (DXA) can predict cardiovascular disease in patients with type 2 diabetes: a retrospective observational study.使用双能 X 射线吸收法(DXA)评估的肌少症性肥胖可以预测 2 型糖尿病患者的心血管疾病:一项回顾性观察研究。
Cardiovasc Diabetol. 2018 Apr 10;17(1):55. doi: 10.1186/s12933-018-0700-5.
7
Prevalence of sarcopenia and predictors of skeletal muscle mass in healthy, older men and women.健康老年男性和女性的肌肉减少症患病率及骨骼肌质量的预测因素
J Gerontol A Biol Sci Med Sci. 2002 Dec;57(12):M772-7. doi: 10.1093/gerona/57.12.m772.
8
Relationship between skeletal muscle mass and cardiac function during exercise in community-dwelling older adults.社区老年人运动时骨骼肌量与心功能的关系。
ESC Heart Fail. 2017 Nov;4(4):409-416. doi: 10.1002/ehf2.12158. Epub 2017 Apr 10.
9
Developing a screening tool for sarcopenia in hospitalized geriatric patients: Estimation of appendicular skeletal muscle mass using bioelectrical impedance.开发一种针对老年住院患者肌少症的筛查工具:利用生物电阻抗评估四肢骨骼肌质量。
Clin Nutr. 2020 Jul;39(7):2233-2237. doi: 10.1016/j.clnu.2019.10.005. Epub 2019 Oct 14.
10
MSRA has low concordance with skeletal muscle mass index in mixed cancer patients: A preliminary and feasibility study.在混合癌症患者中,肌肉减少症相对评估(MSRA)与骨骼肌质量指数的一致性较低:一项初步可行性研究。
Clin Nutr ESPEN. 2022 Dec;52:245-249. doi: 10.1016/j.clnesp.2022.11.002. Epub 2022 Nov 5.

引用本文的文献

1
Loop Diuretics and Sarcopenia: A Potential Association.袢利尿剂与肌肉减少症:一种潜在关联
Muscles. 2023 Sep 22;2(4):317-326. doi: 10.3390/muscles2040024.
2
Low lean mass and all-cause mortality risk in the middle-aged and older population: a dose-response meta-analysis of prospective cohort studies.中年及老年人群中低瘦体重与全因死亡风险:前瞻性队列研究的剂量反应荟萃分析
Front Med (Lausanne). 2025 Jun 25;12:1589888. doi: 10.3389/fmed.2025.1589888. eCollection 2025.
3
Comparison of the performance of four screening tools for sarcopenia in patients with chronic liver disease.
慢性肝病患者中四种肌肉减少症筛查工具的性能比较。
Int J Nurs Sci. 2023 Dec 31;11(1):3-10. doi: 10.1016/j.ijnss.2023.12.014. eCollection 2024 Jan.
4
Beyond the current knowledge on sarcopenia: new insight on neuromuscular factors.超越当前对肌肉减少症的认知:对神经肌肉因素的新见解。
Aging Clin Exp Res. 2022 May;34(5):1183-1185. doi: 10.1007/s40520-022-02082-3. Epub 2022 Feb 14.
5
Aging, obesity, sarcopenia and the effect of diet and exercise intervention.衰老、肥胖、肌肉减少症以及饮食和运动干预的影响。
Exp Gerontol. 2021 Nov;155:111561. doi: 10.1016/j.exger.2021.111561. Epub 2021 Sep 23.